Valuation: Olympus Corporation

Market Cap 1,878B 11.64B 10.18B 9.35B 8.72B 16.54B 1,109B 16.79B 112B 43.66B 545B 43.71B 42.77B P/E 2027 *
19.5x
P/E 2028 * 16.2x
Enterprise Value 1,948B 12.08B 10.56B 9.7B 9.04B 17.15B 1,150B 17.41B 116B 45.28B 565B 45.33B 44.36B EV / Sales 2027 *
1.83x
EV / Sales 2028 * 1.74x
Free-Float
94.53%
Yield 2027 *
1.74%
Yield 2028 * 1.82%
1 day+5.76%
1 week+2.31%
Current month+1.91%
1 month-5.96%
3 months+9.12%
6 months-18.08%
Current year-15.94%
1 week 10.07
Extreme 10.07
10.73
1 month 9.8
Extreme 9.8
11.39
Current year 8.08
Extreme 8.08
13.55
1 year 8.08
Extreme 8.08
13.73
3 years 8.08
Extreme 8.08
19.69
5 years 8.08
Extreme 8.08
74.99
10 years 6.26
Extreme 6.2625
74.99
Manager TitleAgeSince
Chief Executive Officer 63 31/05/2025
Director of Finance/CFO 59 31/03/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 31/03/2023
Director/Board Member 41 31/05/2019
Director/Board Member 63 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+5.76%+2.31% - - 11.64B
+1.97%+2.03%+21.92%+0.55% 195B
+5.87%+5.27%-21.76%+27.59% 151B
+2.17%+0.89%-2.59%-16.62% 140B
+4.83%+2.06%-56.73%-15.23% 67.09B
+2.59%+3.95%+22.89%+3.75% 54.34B
+0.03%+2.19%-25.17%-30.62% 44.63B
+0.31%+1.30%+8.30%+42.29% 37.24B
-2.02%-3.91%+7.67%+9.36% 36.91B
+4.24%+4.66%-18.42%-3.15% 30.24B
Average +2.58%+2.74%-7.10%+1.99% 83.99B
Weighted average by Cap. +2.83%+3.44%-4.01%+2.09%

Financials

2027 *2028 *
Net sales 1,065B 6.6B 5.77B 5.31B 4.95B 9.38B 629B 9.52B 63.7B 24.76B 309B 24.79B 24.26B 1,107B 6.86B 6B 5.51B 5.14B 9.75B 653B 9.89B 66.17B 25.72B 321B 25.75B 25.2B
Net income 98.47B 611M 534M 491M 457M 867M 58.13B 880M 5.89B 2.29B 28.58B 2.29B 2.24B 118B 729M 637M 586M 546M 1.04B 69.4B 1.05B 7.03B 2.73B 34.11B 2.74B 2.68B
Net Debt 69.9B 433M 379M 348M 325M 616M 41.27B 625M 4.18B 1.63B 20.29B 1.63B 1.59B 51.9B 322M 281M 259M 241M 457M 30.64B 464M 3.1B 1.21B 15.06B 1.21B 1.18B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
02/07/26 US$10.65 +5.76% 102,709
01/07/26 US$10.07 -3.64% 38,227
30/06/26 US$10.45 -1.97% 82,384
29/06/26 US$10.66 +2.40% 75,890
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,768.00JPY
Average target price
1,913.08JPY
Spread / Average Target
+8.21%

Quarterly revenue - Rate of surprise